CGEM
Cullinan TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
CGEM vs peer average
42/100
CGEM vs. peer average (D vs. C)
Grade spread
B 1 · C 4 · D 4 · F 1
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
JANX is the first available peer comparator.
Closest listed peer of the set for event-driven clinical-stage immunotherapy valuation; still not a direct indication match, but useful for comparing T-cell-engager sentiment and binary data-readout risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CGEM
Cullinan Therapeutics
JANX
Janux Therapeutics
Grade
D
D
Momentum
88
42
Value
41
41
Sentiment
28
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs JANX
CGEM / JANX
Grade Position
Below peers
CGEM vs. peer average (D vs. C)
42/100
Momentum
88
CGEMValue
41
CGEMSentiment
28
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CGEM
JANX is the first peer returned for this comparison set.